Laurent Fischer - 13 Jun 2024 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
13 Jun 2024
Transactions value $
$0
Form type
4
Filing time
14 Jun 2024, 17:00:42 UTC
Previous filing
07 Jun 2024
Next filing
06 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +206K $0.00 206K 13 Jun 2024 Common Shares 206K $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 1/3rd of the underlying shares on June 13, 2025 and as to the remaining underlying shares in twenty-four (24) substantially equal monthly installments thereafter, such that the option will become fully vested on June 13, 2027.